HON vs IEX Stock Comparison
Compare HON and IEX across AIQ Score, fundamentals, valuation, momentum, risk, analyst expectations and current market evidence.
What is the main difference between HON and IEX?
HON leads the current stock comparison as Honeywell International Inc., with the clearest separation coming from value and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
Honeywell International Inc. vs IDEX Corporation
HON leads
HON leads by 5 AIQ points, primarily on Value and Quality, having only recently taken the lead back from IEX.
Fragile: 3 of 6 evidence groups support HON, the lead recently changed hands, and its current signal state is conflicted.
Honeywell International Inc.
IDEX Corporation
The Algovestiq AIQ Score currently favors HON over IEX, 54 versus 49 as of Sep 11, 2026. HON's advantage is driven primarily by stronger value and quality, while IEX holds the stronger risk resilience profile. HON also shows the weaker technical structure relative to its 50-day moving average. 3 of 6 covered evidence groups favor HON today, and the comparison is rated Fragile on stability: the AIQ gap is narrow at 5 points. HON lead: Reversed — IEX led by 2 AIQ points 30 sessions ago; HON now leads by 5.
Compare Honeywell International Inc. and IDEX Corporation across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Price-return comparison using available daily close history.
Total return comparison
Growth of $10,000
Based on available close-price history. Distribution reinvestment is not added unless already reflected in the source series.
Compare HON and IEX against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Value68 vs 44HON +24
- Risk Resilience62 vs 78IEX +16
- Quality66 vs 56HON +10
- Momentum20 vs 28IEX +8
3 of 6 evidence groups favor HON. HON’s edge is concentrated in value and quality; IEX keeps a meaningful risk resilience edge.
What changed since the last close
Latest scored session 2026-09-10, compared against the prior scored session 2026-09-09.
Largest factor move: Momentum +1
No new signals fired.
Largest factor move: Momentum -2
No new signals fired.
HON's lead was unchanged in the latest snapshot.
Deeper signal detail for each name lives on its own signals page — HON and IEX both carry a full feed there.
The central trade-off
HON (Honeywell International Inc.): the stronger current systematic profile, led by value and quality.
IEX (IDEX Corporation): the counter-case, on risk resilience, momentum, fundamentals.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
HONHON on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
IEXIEX on combined revenue and EPS growth.
Value
HONHON on the peer-relative Value factor, by 24 points.
Momentum
IEXIEX on the Momentum factor, by 8 points.
Lower downside
IEXIEX on Risk Resilience, by 16 points.
Analyst upside
HONHON on implied upside to the consensus price target.
AIQ vs Wall Street
Where the systematic read and the analyst consensus line up — and where they do not.
| Measure | HON | IEX | Note |
|---|---|---|---|
| Implied upside to target | +27.7% | +12.4% | HON has more room |
| Target dispersion | +47.6% | +26.2% | Lower is tighter analyst agreement |
| Consensus | Buy | Buy | Context, not a primary driver |
| Analysts covering | 11 | 8 | Higher coverage generally improves confidence |
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
3 of 6 covered evidence groups favor HON. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | HON | 54 vs 49 |
| Fundamentals | IEXon balance | revenue growth 6.3% vs 3.8%; EPS growth 5.9% vs 20.5%; TTM ROE 41.7% vs 12.9%; gross margin 36.6% vs 44.7%; operating margin 14.1% vs 20.8% — IEX takes 3 of 5 decided legs, not all of them |
| Valuation | HON | Value 68 vs 44 |
| Technicals | IEX | Price vs 50-day -11% vs -1.9%; vs 200-day -7.6% vs 7.1% |
| Risk Resilience | IEX | Risk Resilience 62 vs 78 |
| Analyst expectations | HON | Target upside 27.7% vs 12.4% |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of HON and IEX and are excluded from the count.
AIQ Decision Stability
The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.
- The AIQ gap is narrow at 5 points. (argues the conclusion is provisional)
- Only 3 of 6 covered evidence groups agree. (argues the conclusion is provisional)
- The lead has already changed hands inside the comparison window. (argues the conclusion is provisional)
- The leader is throwing conflicting signals. (argues the conclusion is provisional)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on HON.
How the comparison changed
119 daily snapshots · May 4 – Sep 10HON lead: Reversed — IEX led by 2 AIQ points 30 sessions ago; HON now leads by 5.
- Today
- HON +5
- 54 vs 49
- 7 sessions ago
- HON +6
- 54 vs 48
- 30 sessions ago
- IEX +2
- 55 vs 57
- 90 sessions ago
- HON +7
- 63 vs 56
The lead changed hands 4 times in this window, most recently on Aug 12 when IEX moved ahead of HON.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
2 bullish / 2 bearish, conflicted
- Golden Cross Active — bullish, trend, long horizon (2.44%)
- Keltner Channel Breakdown — bearish, volatility, short horizon
- RSI Oversold - Potential Bounce — bullish, momentum, short horizon
1 bullish / 1 bearish, conflicted
- Golden Cross Active — bullish, trend, long horizon (10.52%)
- MACD Bearish Crossover — bearish, momentum, short horizon
HON leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +0.09%, AIQ 0 points).
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +1.24%, AIQ 0 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1IEX closes the Value gap — currently 24 points behind, the largest single contributor to HON's edge.
- 2IEX's MACD Bearish Crossover resolves — a bearish momentum rule currently active against it.
- 3HON's conflicting signal state resolves bearish — it currently carries 2 bullish and 2 bearish rules at once.
- 4A regime shift changes factor weighting — Quality and Value carry the heaviest weights in the composite, so a rotation toward either would move the result most.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
IEX leads on balance| Metric | HON | IEX |
|---|---|---|
| Revenue growth (YoY) | 6.3% | 3.8% |
| EPS growth (YoY) | 5.9% | 20.5% |
| Gross margin | 36.6% | 44.7% |
| Operating margin | 14.1% | 20.8% |
| Return on equity (TTM) | 41.7% | 12.9% |
| Debt to equity | 1.35 | 0.47 |
Performance
IEX leads 6 of 6 windows| Metric | HON | IEX |
|---|---|---|
| 1 week (5 sessions) | -1.9% | -1.4% |
| 1 month (20 sessions) | -14.1% | -7.9% |
| 3 months (63 sessions) | -1.8% | 3.2% |
| 6 months (126 sessions) | -15% | 13.9% |
| Year to date | 3.6% | 24.5% |
| 1 year (252 sessions) | -0.1% | 34.9% |
Technicals
IEX has the stronger structure| Metric | HON | IEX |
|---|---|---|
| RSI (14) | 27 | 30.4 |
| ADX (14) | 36.1 | 26.1 |
| Price vs 50-day | -11% | -1.9% |
| Price vs 200-day | -7.6% | 7.1% |
| Volatility (1M, annualized) | 19% | 18.1% |
Risk
IEX is the more resilient| Metric | HON | IEX |
|---|---|---|
| Beta | 0.8 | 0.69 |
| Sharpe ratio | -0.01 | 1.33 |
| Sortino ratio | -0.02 | 2.39 |
| Max drawdown | -18.7% | -14.5% |
| Current drawdown | -18.7% | -7.9% |
| Annualized volatility | 26.5% | 22.5% |
| Value at risk (95%) | -2.5% | -1.9% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, HON or IEX?
On the Algovestiq AIQ Score, HON is the stronger of the two as of Sep 11, 2026, scoring 54 against IEX's 49. The edge comes from value and quality. IEX is not without a case — it holds the better risk resilience profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is HON or IEX the better buy right now?
HON carries the stronger systematic profile as of Sep 11, 2026, and the comparison is rated Fragile — 3 of 6 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: the AIQ gap is narrow at 5 points. Treat the lead as provisional.
Why does the AIQ Score favor HON over IEX?
The composite weights Quality, Value, Momentum and Risk Resilience. HON leads Value by 24 points; IEX leads Risk Resilience by 16 points; HON leads Quality by 10 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, HON or IEX?
Analyst price targets imply +27.7% upside for HON and +12.4% for IEX, so the Street currently favors HON. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, HON or IEX?
HON is the better-valued of the two on the peer-relative Value factor. HON on the peer-relative Value factor, by 24 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, HON or IEX?
IEX on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, HON or IEX?
IEX on the Momentum factor, by 8 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, HON or IEX?
IEX is the more resilient of the two, so the other name carries the higher downside risk. IEX on Risk Resilience, by 16 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is HON more profitable than IEX?
The profitability evidence is mixed: gross margin 36.6% vs 44.7%; operating margin 14.1% vs 20.8%; ttm roe 41.7% vs 12.9%. HON leads on one measure and IEX on two measures, and there is no single profitability composite that resolves the split — which of the two reads as "more profitable" depends on whether you weight pricing power or operating leverage.
Is HON's lead over IEX getting stronger or weaker?
HON lead: Reversed — IEX led by 2 AIQ points 30 sessions ago; HON now leads by 5. This is measured from 119 daily comparison snapshots between 2026-05-04 and 2026-09-10. The lead has changed hands 4 times in that window, most recently on 2026-08-12, when IEX moved ahead of HON.
What would change the HON vs IEX verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: IEX closes the Value gap — currently 24 points behind, the largest single contributor to HON's edge; IEX's MACD Bearish Crossover resolves — a bearish momentum rule currently active against it; HON's conflicting signal state resolves bearish — it currently carries 2 bullish and 2 bearish rules at once; a regime shift changes factor weighting — Quality and Value carry the heaviest weights in the composite, so a rotation toward either would move the result most.
What do the current signals say about HON and IEX?
HON: 2 bullish / 2 bearish, conflicted. IEX: 1 bullish / 1 bearish, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on HON is Golden Cross Active (bullish, long horizon). On IEX it is Golden Cross Active (bullish, long horizon).
Compare HON and IEX with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.